2019 Asembia Recap

July 18, 2019

Pharmacists have growing opportunities to help people living with schizophrenia and bipolar disorder.

June 14, 2019

Cohesion among key stakeholders, which will lead to an evolution in care, is clearly on the rise, and the growth of those relationships will only benefit patients in the end.

June 14, 2019

The annual Asembia Specialty Pharmacy Summit has become the largest meeting in the specialty space, and this year it exceeded prior numbers in attendance and offerings in programing.

June 14, 2019

With drug pricing increasingly becoming a hot button issue and greater consternation surrounding the cost of treating a chronic disease among the general public, it is clear that the health care industry is at a crossroads.

June 14, 2019

Patients treated for idiopathic pulmonary fibrosis (IPF) respond well to the high-touch specialty pharmaceutical service model.

June 14, 2019

Health system specialty pharmacies (HSSPs) are uniquely positioned to provide valuable data and superior care to the patients they serve.

June 14, 2019

For many years, a diagnosis of ovarian cancer—90% of which involve epithelial ovarian neoplasms—was a death sentence

June 14, 2019

Most American have never heard of hereditary transthyretin amyloidosis (hATTR), which speaks to its very low incidence rate in the population.

June 14, 2019

Chronic inflammatory demyelinating polyneuropathy (CIDP) starts insidiously and presents as either a slowly progressive disease or a relapsing one, with partial or complete recovery between recurrences.

June 14, 2019

For patients at risk for cardiovascular disease who have a less-than-expected response to statins or are intolerant of them, proprotein convertase subtilisin/kexin type 9 (PCSK9) serine protease inhibitors fill an important treatment gap.

June 14, 2019

Still a mystery in terms of cause and cure, pulmonary arterial hypertension (PAH) is a rare and progressive disease, but, fortunately, treatments for the condition have improved.

June 14, 2019

Diagnostic delay is a tragedy for many patients, as it increases the burden of disease and extends time to symptomatic relief or an actual cure.

June 14, 2019

Peanut allergy is not an issue only within the health care community—it is a hot topic of discussion and often discord among parents, teachers, legislators, and media commentators.

June 14, 2019

Chronic lymphocytic leukemia is the most common leukemia in Western nations, and investigators have made great strides in clarifying the epidemiology, pathophysiology, and diagnostic criteria.

June 14, 2019

Treatment for inflammatory bowel disease (IBD) has the best outcomes when patients partner with their medical teams.

June 14, 2019

Although rare, chronic thromboembolic pulmonary arterial hypertension (CTEPH) is of growing interest to specialty pharmacists.

June 14, 2019

Since the growth of specialty pharmacies, genetically acquired bleeding disorders such as von Willebrand disease (vWD) have been among the most common conditions addressed in these practice locations.

June 14, 2019

Characterized by progressive focal muscle weakness that terminates with respiratory muscle failure, amyotrophic lateral sclerosis (ALS) reduces life expectancy by 3 to 5 years.

June 14, 2019

The oncology drug pipeline has experienced rapid growth over the past decade, driven by innovations in cell therapies, immunotherapy, and precision medicine, according to a specialty pipeline update presentation at the Asembia Specialty Pharmacy Summit 2019.

June 14, 2019

Diabetic eye disease, which includes diabetic retinopathy and macular edema, is on specialty pharmacy’s radar, especially because diabetic retinopathy alone increased 89% between 2000 and 2010.

June 14, 2019

The "specialty-lite" platform leverages the current infrastructure of specialty pharmacies with efficient services and emerging technological solutions that focus on ensuring prescription fulfillment with economic feasibility.

June 14, 2019

Digital innovations are opening up a world in which patients can remain better informed about their health and pharmacists can use digital metrics to help their patients make more informed health care decisions.

June 14, 2019

Co-pay accumulator programs are the latest cost management initiative resulting from the constant push and pull between payers, pharmacy benefit managers (PBMs), and manufacturers to reduce drug spend.

June 14, 2019

Throughout the meeting rooms and educational sessions at the Asembia Specialty Pharmacy Summit 2019, there were clear signs that massive change could alter the industry before next year’s meeting.

June 13, 2019

After a flu season that the CDC called one of the deadliest in recent memory, any information that can help clinicians avert patient morbidity and mortality is welcome.

June 13, 2019

A common theme during this year’s summit was the uncertainty about the profitability of the existing specialty pharmaceutical model.